Clinical Trials Sponsored by Canadian Cancer Society

Total 1633 results

National Cancer Institute (NCI)
NRG Oncology; Canadian Cancer Trials Group

Active, not recruiting

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

Head and Neck Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Lip and Oral Cavity Cancer AJCC v8 | Stage... and other conditions

United States, Canada
National Cancer Institute (NCI)
NRG Oncology; Canadian Cancer Trials Group

Active, not recruiting

Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian... and other conditions

United States, Canada, Puerto Rico, Korea, Republic of, Japan
Tulane University
American Cancer Society, Inc.; University Medical Center-New Orleans

Recruiting

EMPOWER 3: Improving Palliative Care Health Literacy and Utilization (EMPOWER 3)

Cancer | Neoplasm Malignant

United States
Jonsson Comprehensive Cancer Center
Society of Nuclear Medecine and Molecular Imaging

Recruiting

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

Breast Carcinoma | Gastric Carcinoma | Head and Neck Carcinoma | Lung Carcinoma | Ovarian Carcinoma | Colon Carcinoma | Esophageal Carcinoma | Kidney Carcinoma | Pancreatic Carcinoma | Uterine Corpus Cancer | Solid Neoplasm

United States
UMC Utrecht
Erasmus Medical Center; Dutch Cancer Society; Quirem Medical B.V.

Completed

HEPAR Primary: Holmium-166-radioembolization in Hepatocellular Carcinoma Patients

Hepatocellular Carcinoma | Hepatocellular Carcinoma Non-resectable

Netherlands
Canadian Cancer Trials Group
Ottawa Hospital Research Institute

Active, not recruiting

MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours

Advanced/Metastatic Solid Tumours

Canada
NCIC Clinical Trials Group

Completed

Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

Canada, Brazil
NCIC Clinical Trials Group

Completed

Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma

Lymphoma

Canada
NCIC Clinical Trials Group

Completed

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

Breast Cancer | Osteoporosis

United States, Canada
NCIC Clinical Trials Group

Completed

Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

Canada
NCIC Clinical Trials Group

Completed

AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer

Colorectal Cancer | Lung Cancer

Canada
NCIC Clinical Trials Group

Completed

OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

Canada
NCIC Clinical Trials Group

Completed

AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Canada
NCIC Clinical Trials Group

Completed

Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma

Lymphoma

Canada
NCIC Clinical Trials Group

Completed

SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Colorectal Cancer

Canada
NCIC Clinical Trials Group

Completed

Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Sarcoma

Canada, United States
NCIC Clinical Trials Group

Completed

Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx

Head and Neck Cancer | Oral Complications

Canada
NCIC Clinical Trials Group

Completed

Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

Canada, United Kingdom
NCIC Clinical Trials Group

Completed

Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer

Endometrial Cancer
NCIC Clinical Trials Group

Completed

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

Lung Cancer

United States, Spain, Canada, Italy, France, Switzerland, Netherlands, Belgium, Germany, Finland, United Kingdom, Poland, Portugal, Austria
NCIC Clinical Trials Group

Completed

ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Prostate Cancer

Canada
NCIC Clinical Trials Group

Completed

Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery

Endometrial Cancer

Canada, United States, Australia
NCIC Clinical Trials Group

Completed

MG98 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States, Canada
NCIC Clinical Trials Group

Completed

Theophylline in Treating Cancer Patients With Shortness of Breath

Quality of Life | Unspecified Adult Solid Tumor, Protocol Specific | Pulmonary Complications

Canada
NCIC Clinical Trials Group

Completed

Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer

Breast Cancer

United States, Canada
NCIC Clinical Trials Group

Completed

Combination Chemotherapy in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

Canada, United States
NCIC Clinical Trials Group

Completed

Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

Breast Cancer

Canada, United States
NCIC Clinical Trials Group

Completed

Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation

Lymphoma

Canada
NCIC Clinical Trials Group

Completed

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

Breast Cancer | Neutropenia

Canada
NCIC Clinical Trials Group

Completed

Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma (IDEC-C2B8)

Lymphoma

Canada
Sunnybrook Health Sciences Centre
Canadian Breast Cancer Foundation

Unknown

Preoperative Imaging in DIEP Flap Breast Reconstruction

Breast Cancer

Canada
University of British Columbia
Canadian Breast Cancer Foundation

Completed

Can Exercise Improve Cancer Associated Cognitive Dysfunction? (chemobrain)

Breast Cancer

Canada
Ottawa Hospital Research Institute
Canadian Breast Cancer Foundation

Completed

Effects of Vitamin D in Patients With Breast Cancer (OTT 12-06)

Breast Cancer

Canada
Sunnybrook Health Sciences Centre
Canadian Breast Cancer Foundation

Completed

An Online Psychoeducational Intervention for Young Women With Breast Cancer and Their Partners (OPIC)

Breast Cancer

Canada
NCIC Clinical Trials Group

Terminated

Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain

Pain | Unspecified Adult Solid Tumor, Protocol Specific | Sleep Disorders | Nausea and Vomiting

Canada
Ottawa Hospital Research Institute
Canadian Breast Cancer Foundation

Completed

Reducing Pain and Disability After Breast Cancer Surgery (RELIeF)

Breast Cancer | Chronic Pain

Canada
NCIC Clinical Trials Group

Completed

Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone Metastases

Bone Metastases

Canada
NCIC Clinical Trials Group

Completed

Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Lymphoma

United States, Canada, Australia
NCIC Clinical Trials Group

Completed

Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma

Melanoma

Canada, United States
NCIC Clinical Trials Group

Completed

Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer

Colorectal Cancer

Canada
NCIC Clinical Trials Group

Completed

Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma

Lymphoma

Canada
NCIC Clinical Trials Group

Completed

Bortezomib in Treating Patients With Mantle Cell Lymphoma

Lymphoma

Canada
NCIC Clinical Trials Group

Terminated

Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer (DART)

Prostate Cancer

Canada
NCIC Clinical Trials Group

Completed

Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor

Head and Neck Cancer

Canada
NCIC Clinical Trials Group

Completed

AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma

Lymphoma | Unspecified Adult Solid Tumor, Protocol Specific

Canada
NCIC Clinical Trials Group

Completed

Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer

Breast Cancer

Canada
Ottawa Hospital Research Institute
Canadian Cancer Trials Group

Completed

Exercise in Men Receiving Radiation Therapy for Prostate Cancer.

Prostatic Neoplasms

Canada
NCIC Clinical Trials Group

Completed

Flavopiridol in Treating Patients With Metastatic Malignant Melanoma

Melanoma (Skin)

Canada
NCIC Clinical Trials Group

Completed

Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

Canada
NCIC Clinical Trials Group

Completed

ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer

Ovarian Cancer

United States, Canada, United Kingdom

Clinical Trials Sponsored by Canadian Cancer Society

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations